RA Capital Management

Latest statistics and disclosures from Ra Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 62 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A/s - SH (ASND) 19.9 $1.3B -5% 10M 125.95
 View chart
Immunogen SH (IMGN) 11.0 $704M +78% 24M 29.65
 View chart
Vaxcyte SH (PCVX) 7.7 $496M 7.9M 62.80
 View chart
Legend Biotech Corp- SH (LEGN) 5.9 $377M 6.3M 60.17
 View chart
Rhythm Pharmaceuticals SH (RYTM) 3.8 $245M -6% 5.3M 45.97
 View chart
Aerovate Therapeutics SH (AVTE) 2.9 $187M 8.3M 22.63
 View chart
Inhibrx SH (INBX) 2.8 $180M 4.7M 38.00
 View chart
Cymabay Therapeutics SH (CBAY) 2.6 $164M 6.9M 23.62
 View chart
Biogen SH (BIIB) 2.2 $138M 533k 258.77
 View chart
Rxsight SH (RXST) 2.1 $137M +11% 3.4M 40.32
 View chart
89bio SH (ETNB) 2.0 $128M 11M 11.17
 View chart
Verona Pharma Plc - SH (VRNA) 2.0 $126M 6.3M 19.88
 View chart
Day One Biopharmaceuticals I SH (DAWN) 1.8 $114M 7.8M 14.60
 View chart
An2 Therapeutics SH (ANTX) 1.8 $114M 5.6M 20.49
 View chart
Tyra Biosciences SH (TYRA) 1.6 $100M 7.2M 13.85
 View chart
Janux Therapeutics SH (JANX) 1.5 $98M 9.2M 10.73
 View chart
Geron Corp SH (GERN) 1.5 $98M 46M 2.11
 View chart
Icosavax SH (ICVX) 1.5 $94M 6.0M 15.76
 View chart
Alpine Immune Sciences SH (ALPN) 1.5 $94M +4% 4.9M 19.06
 View chart
Wave Life Sciences SH (WVE) 1.4 $92M +5% 18M 5.05
 View chart
Newamsterdam Pharma Co Nv SH (NAMS) 1.4 $88M -12% 7.9M 11.17
 View chart
4d Molecular Therapeutics In SH (FDMT) 1.3 $84M 4.2M 20.26
 View chart
Evolent Health Inc - A SH (EVH) 1.3 $84M -6% 2.5M 33.03
 View chart
Axsome Therapeutics SH (AXSM) 1.2 $80M 1.0M 79.59
 View chart
Fulcrum Therapeutics SH (FULC) 1.2 $78M 12M 6.75
 View chart
Cytek Biosciences SH (CTKB) 1.0 $62M 6.8M 9.12
 View chart
Acumen Pharmaceuticals SH (ABOS) 0.9 $57M 15M 3.84
 View chart
Pepgen SH (PEPG) 0.9 $55M 8.1M 6.80
 View chart
Apogee Therapeutics SH (APGE) 0.9 $55M 2.0M 27.94
 View chart
Ars Pharmaceuticals SH (SPRY) 0.8 $52M 9.5M 5.48
 View chart
Nkarta SH (NKTX) 0.8 $52M 7.8M 6.60
 View chart
Vor Biopharma SH (VOR) 0.8 $51M 23M 2.25
 View chart
Iteos Therapeutics SH (ITOS) 0.8 $48M 4.4M 10.95
 View chart
Madrigal Pharmaceuticals SH (MDGL) 0.7 $47M 205k 231.38
 View chart
Urogen Pharma SH (URGN) 0.7 $46M +107% 3.1M 15.00
 View chart
Macrogenics SH (MGNX) 0.6 $39M +1085% 4.1M 9.62
 View chart
Eliem Therapeutics SH (ELYM) 0.6 $36M 13M 2.70
 View chart
Taysha Gene Therapies SH (TSHA) 0.5 $33M 19M 1.77
 View chart
Gh Research SH (GHRS) 0.5 $32M 5.6M 5.80
 View chart
Enliven Therapeutics SH (ELVN) 0.5 $29M 2.1M 13.84
 View chart
C4 Therapeutics SH (CCCC) 0.4 $28M NEW 4.9M 5.65
 View chart
Mineralys Therapeutics SH (MLYS) 0.4 $27M 3.2M 8.60
 View chart
Werewolf Therapeutics SH (HOWL) 0.4 $24M 6.1M 3.86
 View chart
Acrivon Therapeutics SH (ACRV) 0.4 $24M 4.8M 4.92
 View chart
Pliant Therapeutics SH (PLRX) 0.4 $23M -27% 1.3M 18.11
 View chart
Third Harmonic Bio SH (THRD) 0.3 $22M +111% 2.0M 10.97
 View chart
Avidity Biosciences SH (RNA) 0.3 $22M -61% 2.5M 9.05
 View chart
Solid Biosciences SH (SLDB) 0.3 $21M 3.4M 6.14
 View chart
Structure Therapeutics SH (GPCR) 0.3 $20M NEW 487k 40.76
 View chart
Tenaya Therapeutics SH (TNYA) 0.3 $18M -18% 5.5M 3.24
 View chart
Arvinas SH (ARVN) 0.3 $17M NEW 421k 41.16
 View chart
Harpoon Therapeutics SH (HARP) 0.3 $17M NEW 1.5M 11.37
 View chart
Bicycle Therapeutics Plc- SH (BCYC) 0.2 $15M 800k 18.08
 View chart
Curevac Nv SH (CVAC) 0.2 $12M -74% 2.7M 4.21
 View chart
Compass Pathways SH (CMPS) 0.2 $11M 1.3M 8.75
 View chart
Black Diamond Therapeutics I SH (BDTX) 0.2 $9.9M 3.5M 2.81
 View chart
Chimerix SH (CMRX) 0.1 $8.5M +35% 8.8M 0.96
 View chart
Igm Biosciences SH (IGMS) 0.1 $7.8M 938k 8.31
 View chart
Connect Biopharma Holdings L SH (CNTB) 0.1 $3.6M -56% 3.1M 1.18
 View chart
Unicycive Therapeutics SH (UNCY) 0.0 $3.0M 3.5M 0.87
 View chart
Sab Biotherapeutics SH 0.0 $1.6M NEW 2.4M 0.69
 View chart
Newamsterdam Pharma Co Nv-27 SH (NAMSW) 0.0 $1.0M 333k 3.13
 View chart

Past Filings by Ra Capital Management

SEC 13F filings are viewable for Ra Capital Management going back to 2010

View all past filings